Literature DB >> 22958053

Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study.

L Gerber1, M Otgonsuren, A Mishra, C Escheik, A Birerdinc, M Stepanova, Z M Younossi.   

Abstract

BACKGROUND: High intensity exercise improves metabolic status and may potentially mobilise hepatic fat. AIM: To assess the level of physical activity (PA) of subjects with non-alcoholic fatty liver disease (NAFLD).
METHODS: Data were obtained from NHANES (2003-2006). Activity counts obtained from accelerometer readings (ActiGraph, Fort Walton Beach, FL), from 7 consecutive days quantified total PA and time spent engaged in different levels of activity. All measures were counts/minutes/day: (sedentary <100; light 100-0027; moderate, 2020-5999 and vigorous, 6000+). NAFLD was defined as a fatty liver index >60 (FLI) in the absence of other chronic liver disease. Subjects with NAFLD were compared to controls using stratum-specific Chi-squared and t-tests. Simple linear regression analyses (with Taylor series linearised variance estimation and weighting) were used to determine the association between PA levels and NAFLD. P-values <0.05 were considered significant. Statistical analyses were conducted using sudaan version 10.1 and sas version 9.1.
RESULTS: We included 3056 participants. NAFLD patients were older, had higher BMI, larger waist circumference, higher sum of skinfolds, more likely to have insulin resistance (HOMA > 3.0) and type-2 diabetes (all P-values <0.01). Average PA for NAFLD subjects was about 28.7 counts/minute/day less than controls (P < 0.01). Furthermore, NAFLD subjects spent less time participating in activity at any level (P < 0.01). Subjects with NAFLD and DM were in the lowest quartile of average PA as well as moderate-vigorous PA (P < 0.01).
CONCLUSIONS: Data from this study show that non-alcoholic fatty liver disease patients have low level of physical activity and, when they have diabetes mellitus, they perform at the lowest quartile of physical activity and moderate-vigorous physical activity.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22958053     DOI: 10.1111/apt.12038

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  56 in total

1.  Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.

Authors:  Robert J Pattison; James Phillip Esteban; Tomoki Sempokuya; Jakrin Kewcharoen; Sumodh Kalathil; Scott K Kuwada
Journal:  Hawaii J Health Soc Welf       Date:  2020-06-01

Review 2.  Physical activity for the prevention and treatment of metabolic disorders.

Authors:  Luca Montesi; Simona Moscatiello; Marcella Malavolti; Rebecca Marzocchi; Giulio Marchesini
Journal:  Intern Emerg Med       Date:  2013-05-09       Impact factor: 3.397

Review 3.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

4.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 5.  Health Benefits of Light-Intensity Physical Activity: A Systematic Review of Accelerometer Data of the National Health and Nutrition Examination Survey (NHANES).

Authors:  Eszter Füzéki; Tobias Engeroff; Winfried Banzer
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

6.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  Diabetologia       Date:  2016-06       Impact factor: 10.122

Review 7.  Nonmedicinal interventions in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Radu M Nanau; Lawrence B Cohen
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

Review 8.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

9.  Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.

Authors:  Maureen Whitsett; Lisa B VanWagner
Journal:  World J Hepatol       Date:  2015-08-08

10.  Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts.

Authors:  Tracey G Simon; Mi Na Kim; Xiao Luo; Wanshui Yang; Yanan Ma; Dawn Q Chong; Charles S Fuchs; Jeffrey A Meyerhardt; Kathleen E Corey; Raymond T Chung; Meir Stampfer; Xuehong Zhang; Edward L Giovannucci; Andrew T Chan
Journal:  J Hepatol       Date:  2020-01-15       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.